J.B. Chemicals & Pharmaceuticals Lt

BSE: JBCHEPHARM506943ISIN INE572A01036

Healthcare
Pharmaceuticals
BSE 500

Share price

₹2,412.25-93.35 (-3.73%)

as of 16 Jul 2026

52W high: ₹2,509.40
52W low: ₹1,603.05
Off 52W high: -3.87%
1M return: +10.02%
3M return: +22.16%
6M return: +27.35%
1Y return: +45.79%
20D avg volume: 11,848
50 DMA: ₹2,240.97
200 DMA: ₹1,964.79

Key ratios Consolidated

Market cap: ₹38,731 Cr
Current price: ₹2,412.25
52W high / low: ₹2,509.40 / ₹1,603.05
Face value: ₹1.00
P/E: 47.77
P/B: —
EPS (TTM): ₹50.50
Book value / share: —
ROE: —
ROCE: 21.90%
Operating margin: —
Net margin: —
Debt / equity: 0.00
Net debt: ₹-110.18 Cr
Interest cover: 171.97
Dividend yield: 1.20%
Dividend / share (TTM): ₹29.00
Payout: 57.43%
Cash conversion cycle: 94.4 days

Financials

Metric	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24	Q1 FY24
Income statement
	904.23	1,065	1,085	1,094	949.48	963.49	1,001	1,004	861.73	844.51	881.74	896.20
	11.98	18.28	15.34	14.55	14.48	8.00	9.95	5.89	16.63	7.35	7.66	5.63
	754.34	816.13	821.09	836.88	770.93	753.50	774.04	770.45	713.76	667.91	680.74	707.53
	233.71	212.01	225.34	241.38	188.97	200.23	179.20	251.63	177.18	198.94	221.35	218.81
	102.82	104.34	121.34	149.41	135.96	109.84	150.14	101.01	175.80	78.42	78.19	80.21
	198.73	191.42	188.26	194.29	176.82	173.31	170.57	166.91	152.70	151.68	148.28	148.75
	1.23	1.88	1.35	1.11	1.45	2.58	2.06	5.64	9.41	12.49	10.37	12.06
	50.01	45.35	44.44	42.70	46.44	41.94	41.88	40.78	40.74	34.03	32.17	31.38
	230.12	248.05	241.55	251.68	224.58	218.93	221.11	217.37	210.63	196.08	191.75	205.37
	161.87	266.87	279.15	271.61	193.03	217.99	236.53	239.84	164.60	183.95	208.66	194.30
	-27.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	134.69	266.87	279.15	271.61	193.03	217.99	236.53	239.84	164.60	183.95	208.66	194.30
	33.32	68.98	71.33	69.23	47.34	55.50	61.96	63.01	38.44	50.38	58.07	51.98
	101.37	197.89	207.82	202.38	145.69	162.49	174.57	176.83	126.16	133.57	150.59	142.32
	6.35	12.63	13.29	12.99	9.36	10.46	11.24	11.39	8.22	8.62	9.72	18.39
Key metrics
	185.93	314.10	324.94	315.42	240.92	262.51	280.47	286.26	214.75	230.47	251.20	237.74
	20.60%	29.50%	30.00%	28.80%	25.40%	27.20%	28.00%	28.50%	24.90%	27.30%	28.50%	26.50%
	11.20%	18.60%	19.20%	18.50%	15.30%	16.90%	17.40%	17.60%	14.60%	15.80%	17.10%	15.90%
	3.10%	—	6.90%	—	5.30%	—	—	—	—	—	—	—
	-4.80%	10.50%	8.40%	8.90%	10.20%	14.10%	13.50%	12.10%	—	—	—	—
	-30.40%	21.80%	19.00%	14.40%	15.50%	21.70%	15.90%	24.20%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Income statement
	4,148	4,148	3,918	3,484	3,149	2,424	2,043	1,775	1,643	1,414	1,368
	60.15	60.15	38.32	37.27	9.94	39.23	112.38	50.67	41.44	36.58	50.16
	3,228	3,228	3,069	2,770	2,604	1,959	1,558	1,467	1,398	1,256	1,189
	912.44	912.44	820.03	816.28	783.98	602.22	542.39	452.48	453.75	387.02	367.09
	477.91	477.90	496.95	412.62	395.22	258.17	200.37	182.31	162.10	157.40	—
	772.70	772.70	687.61	601.41	543.45	439.24	340.60	322.92	288.18	251.10	—
	5.57	5.57	11.73	44.33	36.05	5.12	7.24	3.03	4.20	3.49	5.37
	182.50	182.50	171.04	138.32	114.41	72.66	68.67	66.32	55.64	—	47.22
	971.40	971.39	881.99	803.83	741.88	598.61	440.01	443.44	453.17	406.76	401.42
	979.50	979.51	887.39	751.51	555.23	504.90	596.88	358.89	286.99	193.95	229.94
	-27.18	-27.18	0.00	0.00	0.00	0.00	0.00	-10.00	0.00	0.00	0.00
	952.32	952.33	887.39	751.51	555.23	504.90	596.88	348.89	286.99	193.95	229.94
	242.86	242.86	227.81	198.88	145.23	118.86	148.36	76.50	93.02	55.23	45.55
	709.46	709.47	659.58	552.63	410.00	386.04	448.52	272.39	193.97	138.72	184.40
	45.26	45.16	42.45	35.66	53.00	49.86	57.96	34.20	23.54	—	—
Key metrics
	1,140	1,140	1,070	934.16	705.69	582.68	672.79	418.24	346.83	197.44	282.53
	27.49%	27.50%	27.30%	26.80%	22.40%	24.00%	32.90%	23.60%	21.10%	14.00%	20.60%
	17.10%	17.10%	16.80%	15.90%	13.00%	15.90%	22.00%	15.30%	11.80%	9.80%	13.50%
	—	21.90%	24.70%	—	—	—	—	—	—	—	—
	—	5.90%	12.50%	10.60%	29.90%	18.70%	15.10%	8.00%	16.20%	3.30%	—
	—	7.60%	19.40%	34.80%	6.20%	-13.90%	64.70%	40.40%	39.80%	-24.80%	—
	—	703.93	804.86	—	—	—	—	—	—	—	—
	—	0.99	1.37	—	—	—	—	—	—	—	—
	—	0.00	0.00	—	—	—	—	—	—	—	—
	—	-110.18	-101.29	—	—	—	—	—	—	—	—
	—	94.4	87.0	—	—	—	—	—	—	—	—
Balance sheet
	—	4,969	4,274	—	—	—	—	—	—	—	—
	—	2,946	1,934	—	—	—	—	—	—	—	—
	—	110.18	115.09	—	—	—	—	—	—	—	—
	—	780.91	815.38	—	—	—	—	—	—	—	—
	—	683.40	528.95	—	—	—	—	—	—	—	—
	—	—	116.83	—	—	—	—	—	—	—	—
	—	611.63	609.94	—	—	—	—	—	—	—	—
	—	390.98	410.72	—	—	—	—	—	—	—	—
	—	591.18	632.33	—	—	—	—	—	—	—	—
	—	0.00	13.80	—	—	—	—	—	—	—	—
	—	0.00	13.80	—	—	—	—	—	—	—	—
	—	0.00	0.00	—	—	—	—	—	—	—	—
	—	4,159	3,433	—	—	—	—	—	—	—	—
Cash flow
	—	703.93	902.45	—	—	—	—	—	—	—	—
	—	-585.88	-295.89	—	—	—	—	—	—	—	—
	—	-123.11	-579.68	—	—	—	—	—	—	—	—
	—	0.00	97.59	—	—	—	—	—	—	—	—

Metric	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24	Q1 FY24
Income statement
	836.43	990.91	1,023	1,040	901.34	913.51	955.76	952.31	809.20	800.10	836.76	852.58
	10.24	16.89	14.25	13.90	13.53	7.16	8.89	5.16	16.10	6.61	6.84	5.13
	691.39	766.62	768.41	788.84	715.70	711.14	730.45	723.26	662.19	630.30	642.88	659.61
	233.80	212.03	225.36	240.83	188.97	200.18	179.22	251.67	177.16	198.77	221.36	218.75
	97.57	91.71	107.51	121.35	104.13	94.17	139.14	79.21	153.40	59.63	60.79	68.43
	183.92	179.46	177.01	182.04	166.12	163.54	160.46	156.67	143.11	141.66	141.44	139.17
	1.33	1.59	1.01	0.66	0.93	1.85	2.02	4.32	8.32	11.52	9.46	11.21
	48.56	43.62	43.11	41.40	44.41	41.18	40.85	40.01	39.72	33.37	31.50	30.65
	205.23	231.16	222.24	233.71	200.79	202.34	203.27	199.57	193.57	183.06	178.99	189.16
	155.28	241.18	268.49	264.96	199.17	209.53	234.20	234.21	163.11	176.41	200.72	198.10
	-27.18	0.00	0.00	0.00	0.00	—	—	—	—	—	—	—
	128.10	241.18	268.49	264.96	199.17	209.53	234.20	234.21	163.11	176.41	200.72	198.10
	31.56	61.91	68.07	67.09	49.37	53.14	61.08	60.98	37.26	48.49	55.70	53.53
	96.54	179.27	200.42	197.87	149.80	156.39	173.12	173.23	125.85	127.92	145.02	144.57
	6.05	11.45	12.82	12.70	9.63	10.06	11.15	11.16	8.11	8.25	9.36	18.68
Key metrics
	177.99	286.39	312.61	307.02	244.51	252.56	277.07	278.54	211.15	221.30	241.68	239.96
	21.30%	28.90%	30.60%	29.50%	27.10%	27.60%	29.00%	29.20%	26.10%	27.70%	28.90%	28.10%
	11.50%	18.10%	19.60%	19.00%	16.60%	17.10%	18.10%	18.20%	15.60%	16.00%	17.30%	17.00%
	3.00%	—	6.80%	—	5.60%	—	—	—	—	—	—	—
	-7.20%	8.50%	7.00%	9.20%	11.40%	14.20%	14.20%	11.70%	—	—	—	—
	-35.60%	14.60%	15.80%	14.20%	19.00%	22.30%	19.40%	19.80%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Income statement
	3,890	3,890	3,723	3,299	2,884	2,190	1,892	1,641	1,501	1,255	1,199
	55.28	55.28	34.74	34.68	8.65	38.61	111.89	49.34	40.23	35.26	45.89
	3,015	3,015	2,881	2,595	2,366	1,757	1,410	1,341	1,272	1,111	1,028
	912.02	912.02	820.04	816.04	783.78	601.87	542.17	452.10	453.75	387.02	367.09
	418.14	418.15	416.65	342.25	280.43	167.40	99.29	114.50	104.26	93.04	—
	722.43	722.43	646.79	565.38	499.95	399.06	305.98	293.78	257.98	217.31	—
	4.59	4.59	9.12	40.52	34.31	4.95	7.19	2.94	4.12	3.41	5.00
	176.69	176.69	166.45	135.24	111.99	71.28	67.36	65.09	54.82	55.95	46.26
	892.34	892.34	805.97	744.77	682.79	538.21	403.89	409.59	418.86	354.60	343.39
	929.91	929.91	877.11	738.34	527.04	471.29	593.71	349.56	269.27	179.04	216.78
	-27.18	-27.18	0.00	—	—	—	—	-10.00	—	—	—
	902.73	902.73	877.11	738.34	527.04	471.29	593.71	339.56	269.27	179.04	216.78
	228.63	228.63	224.57	194.98	138.15	110.29	146.62	71.42	87.22	51.04	43.82
	674.10	674.10	652.54	543.36	388.89	361.00	447.08	268.14	182.06	128.00	172.97
	43.02	42.91	42.00	35.07	50.29	46.71	57.85	33.70	22.15	—	—
Key metrics
	1,084	1,084	1,053	914.10	673.34	547.52	668.26	407.59	328.21	238.40	268.04
	27.87%	27.90%	28.30%	27.70%	23.30%	25.00%	35.30%	24.80%	21.90%	19.00%	22.40%
	17.33%	17.30%	17.50%	16.50%	13.50%	16.50%	23.60%	16.30%	12.10%	10.20%	14.40%
	—	21.30%	24.70%	—	—	—	—	—	—	—	—
	—	4.50%	12.90%	14.40%	31.70%	15.70%	15.30%	9.30%	19.60%	4.70%	—
	—	3.30%	20.10%	39.70%	7.70%	-19.30%	66.70%	47.30%	42.20%	-26.00%	—
	—	564.75	787.96	—	—	—	—	—	—	—	—
	—	0.96	1.35	—	—	—	—	—	—	—	—
	—	0.00	0.00	—	—	—	—	—	—	—	—
	—	-26.36	-76.21	—	—	—	—	—	—	—	—
	—	92.4	83.8	—	—	—	—	—	—	—	—
Balance sheet
	—	4,824	4,178	—	—	—	—	—	—	—	—
	—	2,754	1,790	—	—	—	—	—	—	—	—
	—	26.36	76.21	—	—	—	—	—	—	—	—
	—	711.71	768.09	—	—	—	—	—	—	—	—
	—	643.38	471.64	—	—	—	—	—	—	—	—
	—	—	112.14	—	—	—	—	—	—	—	—
	—	606.24	606.60	—	—	—	—	—	—	—	—
	—	370.93	384.59	—	—	—	—	—	—	—	—
	—	560.91	584.44	—	—	—	—	—	—	—	—
	—	0.00	0.00	—	—	—	—	—	—	—	—
	—	0.00	0.00	—	—	—	—	—	—	—	—
	—	0.00	0.00	—	—	—	—	—	—	—	—
	—	4,038	3,377	—	—	—	—	—	—	—	—
Cash flow
	—	644.89	884.04	—	—	—	—	—	—	—	—
	—	-587.22	-289.93	—	—	—	—	—	—	—	—
	—	-107.67	-574.26	—	—	—	—	—	—	—	—
	—	80.14	96.08	—	—	—	—	—	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +10.49%
Sales CAGR 5Y: +15.51%
Sales CAGR 10Y: —
Profit CAGR 3Y: +20.12%
Profit CAGR 5Y: +8.56%
Profit CAGR 10Y: —
Sales YoY (TTM): +4.48%
Profit YoY (TTM): +3.30%

Consolidated

Sales CAGR 3Y: +9.61%
Sales CAGR 5Y: +15.22%
Sales CAGR 10Y: —
Profit CAGR 3Y: +20.06%
Profit CAGR 5Y: +9.61%
Profit CAGR 10Y: —
Sales YoY (TTM): +5.87%
Profit YoY (TTM): +7.56%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY (TTM)	Profit YoY (TTM)	1Y return
Sun Pharmaceutical Industries Ltd.	4,41,467	1,840.00	36.43	17.90%	+11.41%	+16.54%	+15.97%
Divi's Laboratories Ltd.	2,53,031	9,531.50	86.51	19.00%	+16.35%	+26.84%	+67.50%
Torrent Pharmaceuticals Ltd.	1,85,210	4,869.40	85.91	9.10%	+32.85%	+7.69%	+36.65%
Zydus Lifesciences Limited	1,20,897	1,212.00	26.32	19.20%	+21.11%	-2.51%	+24.17%
Cipla Ltd.	1,12,203	1,388.90	33.44	14.90%	+1.85%	-37.69%	-7.34%
Laurus Labs Limited	1,08,711	2,012.00	99.67	19.70%	+22.62%	+114.95%	+141.62%
Dr. Reddy's Laboratories Ltd.	1,02,035	1,222.50	32.05	13.90%	-0.87%	-44.57%	-2.41%
Mankind Pharma Limited	1,00,764	2,439.55	48.73	13.70%	+13.75%	+8.10%	-1.69%
Aurobindo Pharma Ltd.	97,814	1,700.00	26.36	13.60%	+9.09%	+9.48%	+55.88%
Lupin Ltd	94,286	2,061.85	16.98	28.40%	+28.19%	+49.13%	+7.35%
Glenmark Pharmaceuticals ltd	65,928	2,336.00	36.67	16.20%	+32.94%	+138.48%	+18.56%
Alkem Laboratories Limited	61,804	5,169.10	28.04	18.80%	+13.36%	-5.52%	-4.73%
Biocon Ltd.	61,114	375.00	146.77	2.90%	+9.83%	-36.60%	+10.62%
Abbott India Ltd. S	56,861	26,758.85	35.22	41.90%	+6.29%	+11.18%	-10.07%
GlaxoSmithkline Pharmaceuticals Ltd.	49,091	2,897.85	45.96	55.40%	+5.75%	+12.41%	+8.51%
Ipca Laboratories Ltd.	48,704	1,920.05	35.42	16.40%	+10.59%	+67.91%	+40.09%
Gland Pharma Limited	47,779	2,895.50	42.31	13.70%	+17.57%	+46.55%	+47.68%
Ajanta Pharma Ltd.	44,118	3,530.60	38.87	29.40%	+20.19%	+22.04%	+43.30%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87%	+7.56%	+45.79%
Emcure Pharmaceuticals Limited	36,534	1,925.75	35.85	25.10%	+18.36%	+32.39%	+49.95%
Wockhardt Ltd	35,539	2,187.20	85.85	6.40%	+18.37%	+377.85%	+63.78%
Sai Life Sciences Limited	33,566	1,580.35	92.74	18.10%	—	—	+84.38%
Neuland Laboratories Limited.	27,498	21,433.15	55.24	23.10%	+78.33%	+182.59%	+53.59%
PIRAMAL PHARMA LIMITED	27,486	206.45	-87.64	0.80%	+0.78%	-419.79%	+9.96%
ACUTAAS CHEMICALS LIMITED	26,308	3,213.30	67.92	27.70%	+40.91%	+104.14%	+136.27%

Filings & corporate actions

Recent announcements

Intimation of Effective Date8 Jul 2026 · Company Update / General
Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 20187 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Record Date in the matter of Scheme of Amalgamation of the J.B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited and their respective shareholders7 Jul 2026 · Corp. Action / Record Date
Receipt of Certified copy of Order passed by National Company Law Tribunal, Ahmedabad Bench ("NCLT") regarding the Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited with ....7 Jul 2026 · Company Update / General
Pronouncement of final order by the Hon''ble National Company Law Tribunal, Ahmedabad Bench sanctioning the Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited with Torrent ....6 Jul 2026 · Company Update / General
Closure of trading window30 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Change in Senior Management Personnel30 Jun 2026 · Company Update / Change in Management
Voting Results and Scrutizer''s Report17 Jun 2026 · AGM/EGM / AGM
Proceedings of the Annual General Meeting17 Jun 2026 · AGM/EGM / AGM
Intimation dated June 12, 2026 - Change in Senior Management Personnel15 Jun 2026 · Company Update / Change in Management
Change in Senior Management Personnel12 Jun 2026 · Company Update / Change in Management
Letter to shareholders - Integrated Annual Report 2025-2627 May 2026 · Company Update / General
Newspaper Advertisement26 May 2026 · Company Update / Newspaper Publication
BRSR for FY 2625 May 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Annual Report for FY 2625 May 2026 · Others / Reg. 34 (1) Annual Report
Intimation of Notice of AGM to be held on June 17, 202625 May 2026 · AGM/EGM / AGM
Disclosure of Annual Secretarial Compliance Certificate for the financial year ended March 31, 202622 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Intimation of Record Date21 May 2026 · Corp. Action / Record Date
Newspaper publication20 May 2026 · Company Update / Newspaper Publication
Transcript13 May 2026 · Company Update / Analyst / Investor Meet
Audio recording of Investors/analysts call with Management12 May 2026 · Company Update / Analyst / Investor Meet
Newspaper advertisement pertaining to financial results for the quarter and year ended March 31, 202612 May 2026 · Company Update / Newspaper Publication
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....11 May 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Newspaper advertisement cutting of publication of Notice of hearing of Petition11 May 2026 · Company Update / Newspaper Publication
Recommendation of Final Dividend of Rs. 9.30 (930%) per share of face value Re. 1 each for financial year 2025-2611 May 2026 · Corp. Action / Dividend
Press Release11 May 2026 · Company Update / Press Release / Media Release
Outcome of meeting of the Board of Directors11 May 2026 · Board Meeting / Outcome of Board Meeting
Investors/Analysts call with Management7 May 2026 · Company Update / Analyst / Investor Meet
JB Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/05/2026 ,inter alia, to consider and approve Meeting of the ....5 May 2026 · Board Meeting / Board Meeting
Scrutinizer''s Report28 Apr 2026 · AGM/EGM / Court Convened Meeting
Proceedings of NCLT convened meeting28 Apr 2026 · AGM/EGM / Court Convened Meeting
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 20186 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Change in Key Managerial Personnel1 Apr 2026 · Company Update / Cessation
Newspaper Publication- Notice to Equity Shareholders28 Mar 2026 · Company Update / Newspaper Publication
Intimation of Trading Window closure period27 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
Notice of NCLT convened meeting of equity shareholders27 Mar 2026 · AGM/EGM / Court Convened Meeting
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 in relation to Scheme of Amalgamation25 Mar 2026 · Company Update / General
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 in relation to Scheme of Amalgamation24 Mar 2026 · Company Update / General
Outcome of Postal Ballot - Appointment of Directors24 Mar 2026 · Company Update / General
Result of Postal Ballot24 Mar 2026 · AGM/EGM / Postal Ballot

Corporate actions

Purpose	Ex date	Record date	Payment date
Amalgamation	17 Jul 2026	17 Jul 2026	—
Final Dividend - Rs. - 9.3000	29 May 2026	29 May 2026	—
Interim Dividend - Rs. - 12.7000	11 Feb 2026	11 Feb 2026	—
Final Dividend - Rs. - 7.0000	30 Jul 2025	30 Jul 2025	—
Interim Dividend - Rs. - 8.5000	7 Feb 2025	8 Feb 2025	—
Final Dividend - Rs. - 6.7500	14 Aug 2024	14 Aug 2024	—